Galderma Group AG
Research Galderma Group AG (PY30) on Bullrun: market cap EUR 42.46B, P/E 80.4, dividend yield 0.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPY30
- ExchangeF
- CountrySwitzerland
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 42.46B
- P/E80.4
- Dividend yield0.2%
- Financial periodFY2025
- RevenueEUR 5.24B
- Revenue growth18.0%
- Net incomeEUR 613.00M
- Free cash flowEUR 1.03B
- Gross margin68.9%
Valuation Snapshot
latest market cap is EUR 42.46B; P/E is 80.4; dividend yield is 0.2%.
About Galderma Group AG
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology.
Frequently asked questions
What is Galderma Group AG's market cap?
Galderma Group AG's market capitalization is EUR 42.46B.
What is Galderma Group AG's P/E ratio?
Galderma Group AG's price-to-earnings (P/E) ratio is 80.4.
Does Galderma Group AG pay a dividend?
Galderma Group AG has a dividend yield of 0.2%.
What does Galderma Group AG do?
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology.